FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2590942022> ?p ?o ?g. }

• W2590942022 endingPage "92" @default.
• W2590942022 startingPage "92" @default.
• W2590942022 abstract "92 Background: The impact of fractionated stereotactic body radiation therapy (SBRT) on patient-reported quality of life (QOL) and physician-reported toxicity in patients with recurrent or locally advanced pancreatic cancer (PCA) was prospectively evaluated. Methods: Forty-two PCA patients were treated with 25-33 Gy using SBRT in 5 fractions on a single-institution study. Both patient- and physician-reported outcomes were evaluated prior to SBRT and 4-6 weeks post-SBRT. Eight outcomes were consistently evaluated among both groups—performance status, fatigue, pain, anorexia, nausea, vomiting, constipation, and diarrhea. Patient-reported QOL metrics were assessed using a 4-point Likert scale on the EORTC QLQ-C30 and QLQ-PAN26, while physician-reported toxicities were graded using the NCI CTCAE version 4.0. Comparisons between those with paired patient- and physician-reported outcomes collected prior to and 4-6 weeks after SBRT were made using the Wilcoxon signed-rank test. Results: Of the 42 patients currently enrolled onto the study, 29 had both patient- and physician-reported outcomes collected prior to and 4-6 weeks after SBRT. Fifty-five percent were female and 83% were Caucasian. The median age at diagnosis was 65.6 years (range, 40.8-86.6). There was no significant impairment of any of the 8 physician-reported toxicities, nor were significant changes observed in patient-reported overall health (p = 0.66) or QOL (p = 0.18) scores following SBRT. Patients felt less worried about their future health (mean change [mD] = -0.45, p = 0.02), and an improvement in feeling less attractive as a result of disease and treatment reached borderline significance (mD= 0.31, p = 0.09). However, patients felt limited in planning activities in advance (mD= 0.45, p = 0.02) and were more constipated (mD= 0.38, p = 0.01) 4-6 weeks post-SBRT. Conclusions: Although the numbers are small, patients with unresectable or locally recurrent PCA do not appear to suffer any detriment of overall health or QOL after receiving a five-day course of SBRT. Moreover, this regimen may lead to a more optimistic point of view on future health and/or level of physical attraction. Clinical trial information: NCT01781728." @default.
• W2590942022 created "2017-03-03" @default.
• W2590942022 creator A5002070760 @default.
• W2590942022 creator A5011776853 @default.
• W2590942022 creator A5032506222 @default.
• W2590942022 creator A5038721635 @default.
• W2590942022 creator A5038803238 @default.
• W2590942022 creator A5048788581 @default.
• W2590942022 creator A5051005965 @default.
• W2590942022 creator A5051619233 @default.
• W2590942022 creator A5060335470 @default.
• W2590942022 creator A5080190586 @default.
• W2590942022 creator A5089299130 @default.
• W2590942022 date "2015-10-10" @default.
• W2590942022 modified "2023-09-26" @default.
• W2590942022 title "Stereotactic body radiation therapy and patient-reported quality of life prospectively evaluated in patients with unresectable or recurrent pancreatic cancer." @default.
• W2590942022 doi "https://doi.org/10.1200/jco.2015.33.29_suppl.92" @default.
• W2590942022 hasPublicationYear "2015" @default.
• W2590942022 type Work @default.
• W2590942022 sameAs 2590942022 @default.
• W2590942022 citedByCount "0" @default.
• W2590942022 crossrefType "journal-article" @default.
• W2590942022 hasAuthorship W2590942022A5002070760 @default.
• W2590942022 hasAuthorship W2590942022A5011776853 @default.
• W2590942022 hasAuthorship W2590942022A5032506222 @default.
• W2590942022 hasAuthorship W2590942022A5038721635 @default.
• W2590942022 hasAuthorship W2590942022A5038803238 @default.
• W2590942022 hasAuthorship W2590942022A5048788581 @default.
• W2590942022 hasAuthorship W2590942022A5051005965 @default.
• W2590942022 hasAuthorship W2590942022A5051619233 @default.
• W2590942022 hasAuthorship W2590942022A5060335470 @default.
• W2590942022 hasAuthorship W2590942022A5080190586 @default.
• W2590942022 hasAuthorship W2590942022A5089299130 @default.
• W2590942022 hasConcept C121608353 @default.
• W2590942022 hasConcept C126322002 @default.
• W2590942022 hasConcept C159110408 @default.
• W2590942022 hasConcept C2779517570 @default.
• W2590942022 hasConcept C2779951463 @default.
• W2590942022 hasConcept C2780210213 @default.
• W2590942022 hasConcept C2780580376 @default.
• W2590942022 hasConcept C2780852908 @default.
• W2590942022 hasConcept C2781112942 @default.
• W2590942022 hasConcept C71924100 @default.
• W2590942022 hasConceptScore W2590942022C121608353 @default.
• W2590942022 hasConceptScore W2590942022C126322002 @default.
• W2590942022 hasConceptScore W2590942022C159110408 @default.
• W2590942022 hasConceptScore W2590942022C2779517570 @default.
• W2590942022 hasConceptScore W2590942022C2779951463 @default.
• W2590942022 hasConceptScore W2590942022C2780210213 @default.
• W2590942022 hasConceptScore W2590942022C2780580376 @default.
• W2590942022 hasConceptScore W2590942022C2780852908 @default.
• W2590942022 hasConceptScore W2590942022C2781112942 @default.
• W2590942022 hasConceptScore W2590942022C71924100 @default.
• W2590942022 hasIssue "29_suppl" @default.
• W2590942022 hasLocation W25909420221 @default.
• W2590942022 hasOpenAccess W2590942022 @default.
• W2590942022 hasPrimaryLocation W25909420221 @default.
• W2590942022 hasRelatedWork W2054058610 @default.
• W2590942022 hasRelatedWork W2347684256 @default.
• W2590942022 hasRelatedWork W2367748629 @default.
• W2590942022 hasRelatedWork W2371976426 @default.
• W2590942022 hasRelatedWork W2373981259 @default.
• W2590942022 hasRelatedWork W2384573711 @default.
• W2590942022 hasRelatedWork W2413690771 @default.
• W2590942022 hasRelatedWork W2560239468 @default.
• W2590942022 hasRelatedWork W2586753493 @default.
• W2590942022 hasRelatedWork W2611312191 @default.
• W2590942022 hasVolume "33" @default.
• W2590942022 isParatext "false" @default.
• W2590942022 isRetracted "false" @default.
• W2590942022 magId "2590942022" @default.
• W2590942022 workType "article" @default.